Fuse Science has announced further advancements of its technology partnership with Macular Health.
Fuse Science is a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.
As previously reported, Macular Health has partnered with Fuse Science to develoop new patent pending sublingual drop formulations to enhance treatment for Age-Related Macular Degeneration (AMD).
AMD is a medical condition which usually affects older adults and results in a loss of vision because of damage to the retina.
Beginning tomorrow, November 16th, and continuing through November 19th 2013, Macular Health will showcase the MacuDrop AREDS II Formula at the American Academy of Ophthalmology meeting.
MacuDrop is designed to reduce the progression of AMD beyond current formulations by leveraging the proprietary sublingual technology of Fuse Science.
The partnership is actively focused on the commercialization of up to three new formulations to address AMD which is the leading cause of blindness in people over the age of 50.
